| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $722.7M | +64.5% |
| R&D Expense | $46.6M | +44.6% |
| SG&A Expense | $131.4M | +31.2% |
| Operating Income | $283.5M | +110.8% |
| Interest Expense | $6.7M | -39.8% |
| Pre-tax Income | $294.3M | +279.6% |
| Income Tax | $1.1M | +41.5% |
| Net Income | $293.2M | +282.1% |
| EPS (Basic) | $2.32 | +274.2% |
| EPS (Diluted) | $1.97 | +245.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $202.0M | -53.7% |
| Accounts Receivable | $145.1M | +24.9% |
| Inventory | $59.4M | -3.1% |
| Current Assets | $917.0M | -5.7% |
| Total Assets | $985.9M | -5.1% |
| Current Liabilities | $150.1M | -73.0% |
| Total Liabilities | $404.8M | -50.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $62.7M | -81.3% |
| Capital Expenditures | $7.1M | -24.7% |
| Investing Cash Flow | -$316.0M | -2321.4% |
| Financing Cash Flow | $19.5M | -65.0% |
| Free Cash Flow | $55.6M | -83.0% |
| Stockholders' Equity |
| $581.0M |
| +161.3% |